Injury of Anterior Cruciate Ligament
9
0
0
7
Key Insights
Highlights
Success Rate
78% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 77/100
22.2%
2 terminated out of 9 trials
77.8%
-8.7% vs benchmark
22%
2 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (9)
Real-time Sensorimotor Feedback for Injury Prevention Assessed in Virtual Reality
Injection Pressure & Adductor Canal Block
Sport Cord Test Following ACL Reconstruction
Adductor Canal Block: Continuous Infusion Versus Automatic Intermittent Bolus
Multimodal Assessment of Knee Conditions
Effect of the FIFA 11+ Injury Prevention Program on Performance & Movement Control in Young Female Athletes
Opioid Use in Single Shot Nerve Block vs Continuous Peripheral Nerve Infusion in Anterior Cruciate Ligament (ACL) Repair
Clinical Follow-up After ACL Reconstruction
Comparison of Infiltration Analgesia With Femoral Nerve Block After Hamstrings Anterior Cruciate Ligament Reconstruction